Mice lacking whole-body or hepatic KHK, but not intestinal KHK, showed protection from fructose-induced hepatic steatosis40–42, demonstrating that hepatic fructose catabolism is a key molecular event that triggers NAFLD. The gene discussed is KHK; the disease is metabolic dysfunction-associated steatotic liver disease.